BUPROPION HYDROCHLORIDE (SR) (Page 10 of 10)
Principal Display Panel
NDC 69097-877-03 Rx Only
Twice-A-Day (After Initial Titration)
buPROPion HCL
Extended-release
Tablets, USP (SR)
100 mg
WARNING: Do not use in combination with Zyban® or any
other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
60 Tablets
Cipla
NDC 69097-878-03 Rx Only
Twice-A-Day (After Initial Titration)
buPROPion HCL
Extended-release
Tablets, USP (SR)
150 mg
WARNING: Do not use in combination with Zyban® or any
other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
60 Tablets
Cipla
NDC 69097-879-03 Rx Only
Twice-A-Day (After Initial Titration)
buPROPion HCL
Extended-release
Tablets, USP (SR)
200 mg
WARNING: Do not use in combination with Zyban® or any
other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
60 Tablets
Cipla
BUPROPION HYDROCHLORIDE (SR) bupropion hydrochloride tablet, extended release | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
BUPROPION HYDROCHLORIDE (SR) bupropion hydrochloride tablet, extended release | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
BUPROPION HYDROCHLORIDE (SR) bupropion hydrochloride tablet, extended release | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
Labeler — Cipla USA Inc., (078719707) |
Registrant — Cipla USA Inc., (078719707) |
Establishment | |||
Name | Address | ID/FEI | Operations |
InvaGen Pharmaceuticals Inc. | 165104469 | ANALYSIS (69097-877), ANALYSIS (69097-878), ANALYSIS (69097-879), MANUFACTURE (69097-877), MANUFACTURE (69097-878), MANUFACTURE (69097-879) |
Establishment | |||
Name | Address | ID/FEI | Operations |
InvaGen Pharmaceuticals Inc. | 080334903 | ANALYSIS (69097-877), ANALYSIS (69097-878), analysis (69097-879), pack (69097-877), pack (69097-878), pack (69097-879) |
Revised: 12/2018 Cipla USA Inc.,
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/bupropion-hydrochloride-sr-18/page/10/